Beneficial effects of quercetin on oxidative stress in liver and kidney induced by titanium dioxide (TiO2) nanoparticles in rats

Toxicology Mechanisms and Methods

Volumn 25, Issue 3, 2015, Pages 166-175

  Gonzalez Esquivel, Aaron Emmanuel ^a   Charles Ninõ, Claudia Lisset ^a   Pacheco Moises, Fermin Paul ^a   Ortiz, Genaro Gabriel ^b   Jaramillo Juarez, Fernando ^c   Rincon Sanchez, Ana Rosa ^a  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA DE OCCIDENTE   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE AGUASCALIENTES   (Mexico)

Author keywords

Kidney; Liver; Nanoparticles; Oxidative stress; Quercetin; Rat; Titanium dioxide (TiO2)

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MALONALDEHYDE; QUERCETIN; TITANIUM DIOXIDE NANOPARTICLE; ANTIOXIDANT; METAL NANOPARTICLE; TITANIUM; TITANIUM DIOXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVITY; GENE EXPRESSION; KIDNEY; KIDNEY FUNCTION TEST; LIVER; LIVER FUNCTION TEST; LIVER INJURY; MALE; NONHUMAN; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; URINARY EXCRETION; URINE FLOW RATE; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY; GENE EXPRESSION REGULATION; GENETICS; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIPID PEROXIDATION; METABOLISM; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; RANDOMIZATION; RENAL INSUFFICIENCY; WISTAR RAT;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

ANIMALS; ANTIOXIDANTS; DRUG DELIVERY SYSTEMS; DRUG-INDUCED LIVER INJURY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; KIDNEY; LIPID PEROXIDATION; LIVER; MALE; METAL NANOPARTICLES; OXIDATION-REDUCTION; OXIDATIVE STRESS; QUERCETIN; RANDOM ALLOCATION; RATS, WISTAR; RENAL INSUFFICIENCY; TITANIUM;

EID: 84930251490     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2015.1006491     Document Type: Article

References (49)

1. Alam MM, Meerza D, Naseem I. (2014). Protective effect of quercetin on hyperglycemia, oxidative stress and DNA damage in alloxan induced type 2 diabetic mice. Life Sci 109:8-14.
2. Alarifi S, Ali D, Al-Doaiss AA, et al. (2013). Histologic and apoptotic changes induced by titanium dioxide nanoparticles in the livers of rats. Int J Nanomed 8:3937-43.
3. Al-Rasheed NM, Faddah LM, Mohamed AM, et al. (2013). Potential impact of quercetin and idebenone against immuno-inflammatory and oxidative renal damage induced in rats by titanium dioxide nanoparticles toxicity. J Oleo Sci 62:961-71.
4. Amato I. (1989). Making the right stuff. Sci News 136:108-10.
5. Andersen HR, Nielsen JB, Nielsen F, Grandjean P. (1997). Antioxidative enzyme activities in human erythrocytes. Clin Chem 43:562-8.
6. Baan R, Straif K, Grosse Y, et al. (2006). WHO International Agency for Research on Cancer Monograph Working Group. Carcinogenicity of carbon black, titanium dioxide, and talc. Lancet Oncol 7:295-6
7. Bousová I, Skálová L. (2012). Inhibition and induction of glutathione S-transferases by flavonoids: possible pharmacological and toxicological consequences. Drug Metab Rev 44:267-86.
8. Chen J, Dong X, Zhao J, Tang G. (2009). In vivo acute toxicity of titanium dioxide nanoparticles to mice after intraperitioneal injection. J Appl Toxicol 29:330-7.
9. Chongmu L, Chanseok H, Hohyeong K, et al. (2010). TiO2 nanotubes as a therapeutic agent for cancer thermotherapy. Photochem Photobiol 86:981-9.
10. Ciftci O, Ozdemir I. (2011). Protective effects of quercetin and chrysin against 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) induced oxidative stress, body wasting and altered cytokine productions in rats. Immunopharmacol Immunotoxicol 33:504-8.
11. Cui Y, Gong X, Duan Y, et al. (2010). Hepatocyte apoptosis and its molecular mechanisms in mice caused by titanium dioxide nanoparticles. J Hazard Mater 183:874-80.
12. Cui Y, Liu H, Zhou M, et al. (2011) Signaling pathway of inflammatory responses in the mouse liver caused by TiO2 nanoparticles. J Biomed Mater Res A 96:221-9.
13. Curry FR, Rygh CB, Karlsen T, et al. (2010). Atrial natriuretic peptide modulation of albumin clearance and contrast agent permeability in mouse skeletal muscle and skin: role in regulation of plasma volume. J Physiol 588:325-39.
14. Diesen DL, Kuo PC. (2009). Nitric oxide and redox regulation in the liver: Part I. General considerations and redox biology in hepatitis. J Surg Res 162:95-109.
15. Eckert A, Keil U, Kressmann S, et al. (2003). Effect of EGb 761 Ginkgo biloba extract on mitochondrial function and oxidative stress. Pharmacopsychiatry 36:S15-23.
16. Eisner C, Ow H, Yang T, et al. (2012). Measurement of plasma volume using fluorescent silica-based nanoparticles. J Appl Physiol 112: 681-7.
17. Erlejman AG, Verstraeten SV, Fraga CG, Oteiza PI. (2004). The interaction of flavonoids with membranes: potential determinant of flavonoid antioxidant effects. Free Radic Res 38:1311-20.
18. Esterbauer H, Cheeseman KH. (1990). Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186:407-21.
19. Fabian E, Landsiedel R, Ma-Hock L, et al. (2008). Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats. Arch Toxicol 82:151-7.
20. Ferraresi R, Troiano L, Roat E, et al. (2005). Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin. Free Radic Res 39:1249-58.
21. Flohé L, Günzler WA. (1984). Assays of glutathione peroxidase. Methods Enzymol 105:114-21.
22. Griffith OW. (1980). Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 15:207-12.
23. Gui S, Sang X, Zheng L, et al. (2013). Intragastric exposure to titanium dioxide nanoparticles induced nephrotoxicity in mice, assessed by physiological and gene expression modifications. Part Fibre Toxicol 10:4.
24. Helal I, Fick-Brosnahan GM, Reed-Gitomer B, Schrier RW. (2012). Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol 8:293-300.
25. Homolya L, Váradi A, Sarkadi B. (2003). Multidrug resistanceassociated proteins: export pumps for conjugates with glutathione, glucuronate or sulfate. Biofactors 17:103-14.
26. Hong C, An S, Son M, et al. (2010). In-vitro cell tests using doxorubicinloaded polymeric TiO2 nanotubes used for cancer photothermotherapy. Anticancer Drugs 23:553-60.
27. Kermanizadeh A, Vranic S, Boland S, et al. (2013). An in vitro assessment of panel of engineered nanomaterials using a human renal cell line: cytotoxicity, pro inflammatory response, oxidative stress and genotoxicity. BMC Nephrol 25:14:96.
28. Larson AJ, Symons JD, Jalili T. (2010). Quercetin: a treatment for hypertension A review of efficacy and mechanisms. Pharmaceuticals 3:237-50.
29. Lee C, Hong C, Kim H, et al. (2010). TiO2 nanotubes as a therapeutic agent for cancer thermotherapy. Photochem Photobiol 86:981-9.
30. Lehman-McKeeman LD (2008). Absorption, distribution and excretion of toxicants. In Klaassen CD, ed. Casarett and Doull's toxicology. The basic science of poisons, 7th edn, Chap 5. New York (NY): McGraw-Hill, 131-60.
31. Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-8.
32. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-75.
33. Min K, Ebeler SE. (2008). Flavonoid effects on DNA oxidation at low concentration relevant to physiological levels. Food Chem Toxicol 46: 96-104.
34. Muthukumaran S, Sudheer AR, Menon VP, Nalini N. (2008). Protective effect of quercetin on nicotine-induced prooxidant and antioxidant imbalance and DNA damage in Wistar rats. Toxicology 243:207-15.
35. Oberdörster G, Oberdörster E, Oberdörster J. (2005). Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823-39.
36. Peralta-Videa JR, Zhao L, Lopez-Moreno ML, et al. (2011). Nanomaterials and the environment: a review for the biennium 2008-2010. J Hazard Mater 186:1-15.
37. Pérez A, González-Manzano S, Jiménez R, et al. (2014). The flavonoid quercetin induces acute vasodilator effects in healthy volunteers: correlation with beta-glucuronidase activity. Pharmacol Res 89:11-8.
38. Rasmussen MS, Simonsen JA, Sandgaard NC, et al. (2003). Mechanisms of acute natriuresis in normal humans on low sodium diet. J Physiol 546:591-603.
39. Robaszkiewicz A, Balcerczyk A, Bartosz G. (2007). Antioxidative and prooxidative effects of quercetin on A549 cells. Cell Biol Int 31: 1245-50.
40. Sadauskas E, Jacobson NR, Danscher G, et al. (2009). Bio-disruption of gold nanoparticles in mouse lung following intratracheal instillation. Chem Cent J 3:16-23.
41. Sanvicens N, Marco MP (2008). Multifunctional nanoparticles-properties and prospects for their use in human medicine. Trends Biotechnol 26:425-33.
42. M, Simon Klenovics K, et al. (2014). Comprehensive assessment of nephrotoxicity of intravenously administered sodium-oleate-coated ultra-small superparamagnetic iron oxide (USPIO) and titanium dioxide (TiO2) nanoparticles in rats. Nanotoxicology 8, 142-57.
43. Sha B, Gao W, Wang S, et al. (2013). Nano-titanium dioxide induced cardiac injury in rat under oxidative stress. Food Chem Toxicol 58: 280-8.
44. Sheng L, Wang X, Sang X, et al. (2013). Cardiac oxidative damage in mice following exposure to nanoparticulate titanium dioxide. J Biomed Mater Res A 101:3238-46.
45. Shukla RK, Kumar A, Gurbani D, et al. (2013). TiO(2) nanoparticles induce oxidative DNA damage and apoptosis in human liver cells. Nanotoxicology 7:48-60.
46. Stone V, Johnston H, Clift MJ. (2007). Air pollution, ultrafine and nanoparticle toxicology: cellular and molecular interactions. IEEE Trans Nanobiosci 6:331-40.
47. Traynor J, Mactier R, Geddes CC, Fox JG. (2006). How to measure renal function in clinical practice. BMJ 333:733-7.
48. Vidyashankar S, Sandeep Varma R, Patki PS. (2013). Quercetin ameliorate insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells. Toxicol In Vitro 27:945-53.
49. Wang JX, Fan YB, Gao Y, et al. (2009). TiO2 nanoparticles translocation and potential toxicological effect in rats after intraarticular injection. Biomaterials 30:4590-600.